Letter to our shareholders - June 2019

"The health sector is in great need of innovations, & will continue to be for a long time yet" says Philippe Genne, CEO & founder, Oncodesign Biotechnology.

lettertoshareholders June19

DOWNLOAD OUR LETTER

Letter to our shareholders - November 2018

"I urge you all to stay aboard and keep your eyes firmly fixed on the future:  we believe in it" says Philippe Genne, CEO & founder, Oncodesign Biotechnology.

lts nov18

DOWNLOAD OUR LETTER

Letter to our shareholders - June 2018

"Step by step, we are building our future with innovation" says Philippe Genne, CEO & founder, Oncodesign Biotechnology.

Letter to our shareholders - June 2018

DOWNLOAD OUR LETTER

By closing this message, you consent to our cookies on this device in accordance with our cookie policy unless you have disabled them.